TOP STORIES

• BUSINESS Sanofi-Aventis Looks to Clinical Evidence to Differentiate Lantus from Rival
  September 25, 2012

• ORGANIZATION MHLW Reports Results of Analysis of “Close-Call” Incidents at Pharmacies with Generics
  September 24, 2012

• BUSINESS Pfizer Preparing for Assault on Domestic Generic Drug Market with Help from Mylan
  September 24, 2012

• REGULATORY MHLW to Introduce Brand Name Rules for Combination Injectables to Prevent Medical Accidents
  September 21, 2012

• ORGANIZATION Dr Fukuda Lays Out 4 Options for HTA Introduction in Drug Pricing
  September 20, 2012

• ORGANIZATION Maker FTC Bans Drink Donations at Academic Conferences
  September 19, 2012

• BUSINESS Chugai Provides All-Case PMS Data via iPad, Beginning with Avastin
  September 18, 2012

• BUSINESS JT Sees Silver Lining in Pharmaceutical Biz 25 Yrs after Market Entry; 1st Approval Obtained for Proprietary Drug
  September 14, 2012

• REGULATORY Osaka District Court to Issue Ruling on Actos Patent Suit on Sept. 27
  September 12, 2012

• BUSINESS Wholesalers Unlikely to See Significant Progress in Price Negotiations By End of September
  September 12, 2012

• BUSINESS Pharmaceutical Companies Beefing Up Training for Cancer Specialized MRs
  September 11, 2012

• BUSINESS DSP Revising Midterm Business Plan – Will It Be Able to Hammer Out Effective Measures against Stagnant Domestic Business?
  September 10, 2012

• BUSINESS Kissei Aims for 40% Market Share for Epoetin Alfa at Early Stage
  September 7, 2012

• BUSINESS Nippon Shinyaku Plans Generic Launch to Complement Its New Drug Lineup in Priority Field
  September 6, 2012

• BUSINESS Meiji Seika Pharma Aims to Bolster Presence with COPD Drug Oxis
  September 5, 2012

• BUSINESS RaQualia to Focus on Fields Where It Can Exhibit Uniqueness, Compile Biz Strategy in November
  September 4, 2012

• BUSINESS DSP’s US Subsidiary Sunovion to Acquire Elevation Pharmaceuticals of the US
  September 3, 2012

• REGULATORY MHLW to Seek Funds to Enhance Regulatory Consultation under FY2013 “Priority Budget Scheme”
  September 3, 2012

• BUSINESS Sosei Committed to Becoming a Japan-Based Global Biopharma: Vice President Akihiro Matsuura
  September 3, 2012

• BUSINESS Ribomic Aims to Commercialize Non-Addictive Analgesic Nucleic Acid Drug
  August 30, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 229
• 230
• 231
• 232
• 233
• 234
• 235
• 236
• 237
• …
• Next ›
• 最終 »